Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Merck Millipore experiences growth in 2010

Merck Millipore experiences growth in 2010

24th February 2011

Merck Millipore has experienced significant growth during the fiscal year of 2010, with revenue rising by 81 percent compared to 2009.

The Merck KGaA business unit, which was created in July 2010 from the merger of Millipore and Merck's former performance and life science division, was able to generate a revenue total of 1.68 billion euros (1.43 billion pounds).

This 5.2 billion euro acquisition was also credited with having a transformative effect on the wider group, accounting for 8.4 percentage points of the 20 percent year-on-year revenue increase experienced by Merck KGaA in 2010.

Merck KGaA now expects to see a further revenue rise of between 13 and 18 percent in 2011, thanks in part to the Millipore takeover.

Dr Karl-Ludwig Kley, chairman of the group's executive board, said the buyout has played a key role in "adding new capabilities, scale and innovative products, in line with our long-term strategy".

Last month, Merck Millipore announced that it will be transferring responsibility for distribution of the Incelligent insulin range for cell culture media to Novo Nordisk, the product's manufacturer.ADNFCR-8000103-ID-800426178-ADNFCR

We currently have 7 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.